Cite
HARVARD Citation
Burmester, G. et al. (n.d.). SAT0202 Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with active rheumatoid arthritis in the phase 3 monarch study, including subpopulations. Annals of the rheumatic diseases. p. 849. [Online].